Literature DB >> 17467885

Prostate cancer characteristics in a multiracial community.

Vincent Ravery1, Sébastien Dominique, Vincent Hupertan, Sami Ben Rhouma, Marianne Toublanc, Liliane Boccon-Gibod, Laurent Boccon-Gibod.   

Abstract

OBJECTIVES: To investigate the hypothesis that Northern Africans differ from Caucasians with regard to their PCa characteristics, using our 1988-2006 database we retrospectively reviewed the preoperative and pathological features of consecutive patients subjected to radical prostatectomy (RP) for localized prostate cancer (PCa) and stratified according to their ethnic origin.
METHODS: In 727 consecutive patients (616 Caucasians; 61 Blacks originating from Central Africa and the French West Indies; 50 Northern Africans from Morocco, Algeria, Tunisia), we preoperatively analyzed and compared age, clinical stage of the tumour, prostate-specific antigen (PSA), transrectal ultrasound prostate volume, PSA density (PSAD), biopsy Gleason score, number of positive cores (NPC), and percentage of tissue core invaded by cancer (PTIC); postoperatively, we determined the status of the capsule, seminal vesicles, and margins of the RP specimen, as well as Gleason score and prostate weight. Statistical analyses (chi-square test and ANOVA) were performed to compare the results between the three groups of patients. A multivariate analysis was carried out to test the independence of variables.
RESULTS: Black patients were the youngest at the time of surgery (by 3-4 yr) and had the highest rates of final Gleason score>or=8. The Northern Africans had more favourable features than did Caucasian and Black patients: mean PTIC was 7.1% versus 14.6% and 12.5%, respectively (p=0.005), mean NPC was 26.4% versus 34.7% and 36.4%, respectively (p=0.034), rates of biopsy and final Gleason score>or=8 were significantly lower (p=0.02 and p=0.028, respectively), and there were positive margins in 26% versus 36% and 35.6%, respectively (p>0.05).
CONCLUSIONS: This study showed that a French Black population is the most likely of those studied to have unfavourable PCa characteristics at the time of RP. Albeit in a limited series, we show for the first time that Northern Africans have significantly better features in this regard than Caucasians and Blacks. Although Northern Africans did not have a better pathological stage outcome, they did have a more favourable Gleason score.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17467885     DOI: 10.1016/j.eururo.2007.04.048

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  8 in total

1.  Prostate cancer characteristics and survival in males of African Ancestry according to place of birth: data from Brooklyn-New York, Guyana, Tobago and Trinidad.

Authors:  Batsirai Mutetwa; Emanuela Taioli; Alison Attong-Rogers; Penelope Layne; Veronica Roach; Camille Ragin
Journal:  Prostate       Date:  2010-07-01       Impact factor: 4.104

Review 2.  African-American Prostate Cancer Disparities.

Authors:  Zachary L Smith; Scott E Eggener; Adam B Murphy
Journal:  Curr Urol Rep       Date:  2017-08-14       Impact factor: 3.092

3.  Multi-institutional prostate cancer study of genetic susceptibility in populations of African descent.

Authors:  Emanuela Taioli; Rafael E Flores-Obando; Ilir Agalliu; Pascal Blanchet; Clareann H Bunker; Robert E Ferrell; Maria Jackson; La Creis R Kidd; Suzanne Kolb; Nicol A Lavender; Norma McFarlane-Anderson; Seian S Morrison; Luc Multigner; Elaine A Ostrande; Jong Y Park; Alan L Patrick; Timothy R Rebbeck; Marc Romana; Janet L Stanford; Flora Ukoli; Tiva T Vancleave; Charnita M Zeigler-Johnson; Batsirai Mutetwa; Camille Ragin
Journal:  Carcinogenesis       Date:  2011-06-24       Impact factor: 4.944

Review 4.  Prostate cancer in men of African origin.

Authors:  Kathleen F McGinley; Kae Jack Tay; Judd W Moul
Journal:  Nat Rev Urol       Date:  2015-12-31       Impact factor: 14.432

5.  Genetic ancestry and prostate cancer susceptibility SNPs in Puerto Rican and African American men.

Authors:  Margarita Irizarry-Ramírez; Rick A Kittles; Xuemei Wang; Jeannette Salgado-Montilla; Graciela M Nogueras-González; Ricardo Sánchez-Ortiz; Lourdes Guerrios; Keila Rivera; Ebony Shah; Ina Prokhorova; Pamela Roberson; Patricia Troncoso; Curtis A Pettaway
Journal:  Prostate       Date:  2017-05-24       Impact factor: 4.104

6.  Evaluation of prostate cancer characteristics in four populations worldwide.

Authors:  Charnita M Zeigler-Johnson; Hanna Rennert; R Devi Mittal; Mohamed Jalloh; Rajeev Sachdeva; S Bruce Malkowicz; Anil Mandhani; B Mittal; Serigne M Gueye; Timothy R Rebbeck
Journal:  Can J Urol       Date:  2008-06       Impact factor: 1.344

7.  The role of the serum testosterone levels as a predictor of prostate cancer in patients with atypical small acinar proliferation at the first prostate biopsy.

Authors:  Lucio Dell'Atti; Andrea B Galosi
Journal:  Asian J Androl       Date:  2018 Jan-Feb       Impact factor: 3.285

8.  Relationship between prostate volume changes and treatment duration of neoadjuvant androgen deprivation during intensity-modulated radiation therapy for Japanese patients with prostate cancer.

Authors:  Masashi Tomida; Kuniyasu Okudaira; Takeshi Kamomae; Hiroshi Oguchi; Yoshikazu Miyake; Kazuo Yoneda; Yoshiyuki Itoh
Journal:  Nagoya J Med Sci       Date:  2016-08       Impact factor: 1.131

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.